The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up

被引:0
作者
Arfon G. M. T. Powell
Jenny Ferguson
Fahd Al-Mulla
Clare Orange
Donald C. McMillan
Paul G. Horgan
Joanne Edwards
James J. Going
机构
[1] University of Glasgow,Unit of Experimental Therapeutics, Institute of Cancer Science
[2] University of Glasgow,University Department of Surgery, Faculty of Medicine, Glasgow Royal Infirmary
[3] Kuwait University,University Department of Pathology, Faculty of Medicine, The Health Sciences Center
[4] University of Glasgow,University Department of Pathology, Faculty of Medicine, Glasgow Royal Infirmary
来源
Journal of Cancer Research and Clinical Oncology | 2013年 / 139卷
关键词
Colorectal cancer; Genetic profiling; Curative surgery; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2013 / 2020
页数:7
相关论文
共 160 条
[1]  
Al-Mulla F(2006)Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse Mod Pathol 19 648-658
[2]  
Behbehani AI(1999)Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival Clin Cancer Res 5 3454-3459
[3]  
Bitar MS(2010)Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators Semin Oncol 37 39-46
[4]  
Varadharaj G(2007)New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease Clin Cancer Res 13 6913s-6920s
[5]  
Going JJ(2004)American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 3408-3419
[6]  
Arribas R(2009)Genomic Aberrations in Squamous Cell Lung Carcinoma Related to Lymph Node or Distant Metastases Lung Cancer 66 372-378
[7]  
Ribas M(2005)Inflammation and prognosis in colorectal cancer Eur J Cancer 41 2645-2654
[8]  
Risques RA(2010)A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes’ A colorectal cancer Br J Cancer 103 970-974
[9]  
Masramon L(2012)Review of biomarkers in colorectal cancer Colorectal Dis 14 3-17
[10]  
Tórtola S(2003)Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma Clin Cancer Res 9 2307-2315